State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 282 actively recruiting studies with Arizona sites out of 282 registered in total. The busiest research areas in Arizona are Heart Failure, Prostate Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include Mayo Clinic, AstraZeneca, University of Arizona. By stage, Arizona trials break down as Phase 1 (40), Phase 2 (91), Phase 3 (97), Phase 4 (11).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 282 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 282. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Heart Failure, Prostate Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT06309979 N/A
Recruiting
A Study to Assess Growth in Children With Idiopathic Short Stature
Condition
Idiopathic Short Stature
Enrollment
300 pts
Location
United States
Sponsor
BioMarin Pharmaceutical
NCT06726161 Phase 1, Phase 2
Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Id...
Condition
Hepatocellular Carcinoma (HCC)
Enrollment
590 pts
Location
United States
Sponsor
RayzeBio, Inc.
NCT07767903 Phase 3
Recruiting
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With ...
Condition
Generalized Anxiety Disorder
Enrollment
384 pts
Location
United States
Sponsor
Otsuka Pharmaceutical Developm
NCT06496256 N/A
Recruiting
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Condition
Prostate Cancer
Enrollment
84 pts
Location
United States, Australia
Sponsor
Palette Life Sciences, Inc.
NCT02660645 N/A
Recruiting
Blue Light Cystoscopy With Cysview® Registry
Condition
Bladder Cancer
Enrollment
4,400 pts
Location
United States
Sponsor
Photocure
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
NCT07455383 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
NCT07480356 Phase 3
Recruiting
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice...
Condition
Bladder (Urothelial, Transitional Cell) Cancer
Enrollment
284 pts
Location
United States, Ukraine
Sponsor
Protara Therapeutics
NCT04879329 Phase 2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer Th...
Condition
Urothelial Carcinoma
Enrollment
372 pts
Location
United States, Argentina, Australia
Sponsor
Seagen, a wholly owned subsidi
NCT06772623 Phase 1, Phase 2
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab ...
Condition
Non Small Cell Lung Carcinoma
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT06207188 N/A
Recruiting
Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Vi...
Condition
Thyroid Gland Carcinoma
Enrollment
650 pts
Location
United States
Sponsor
Mayo Clinic
NCT06643741 N/A
Recruiting
Non-Invasive Preeclampsia Screening and Biobank
Condition
Preeclampsia (PE)
Enrollment
6,550 pts
Location
United States
Sponsor
Sequenom, Inc.
NCT07225387 Phase 4
Recruiting
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of...
Condition
Lupus Nephritis
Enrollment
30 pts
Location
United States
Sponsor
NephroNet, Inc.
NCT07804615 Phase 2
Recruiting
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adu...
Condition
PARKINSON DISEASE (Disorder)
Enrollment
80 pts
Location
United States, Canada
Sponsor
Vima Therapeutics
NCT06790693 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor a...
Condition
Breast Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07295847 Phase 1, Phase 2
Recruiting
A Study of AZD0120 in Autoimmune Diseases
Condition
Systemic Sclerosis
Enrollment
27 pts
Location
United States, Australia, Germany
Sponsor
AstraZeneca
NCT05561387 Phase 3
Recruiting
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)...
Condition
Plasma Cell Myeloma
Enrollment
510 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07211958 Phase 3
Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed...
Condition
Acute Myeloid Leukemias
Enrollment
468 pts
Location
United States, Argentina, Australia
Sponsor
Syndax Pharmaceuticals
NCT07737743 Phase 2
Recruiting
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in ...
Condition
Sjögren's Disease
Enrollment
344 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT07518186 Phase 3
Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or ...
Condition
Multiple Myeloma
Enrollment
700 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT06952699 Phase 2
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Condition
Narcolepsy Type 2
Enrollment
88 pts
Location
United States, China, France
Sponsor
Takeda
NCT06603844 Phase 1, Phase 2
Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Condition
Solid Tumor
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Corbus Pharmaceuticals Inc.
NCT06479135 Phase 3
Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With ...
Condition
Myelofibrosis
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Kartos Therapeutics, Inc.
NCT06997497 Phase 3
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy ...
Condition
Colon Adenocarcinoma
Enrollment
477 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology